Medical Condition News

RSS

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.

21 May 2013

People exposed to wood and tobacco smoke are at greater risk for developing COPD

People who are consistently exposed to both wood smoke and tobacco smoke are at a greater risk for developing chronic obstructive pulmonary disease and for experiencing more frequent and severe symptoms of the disease, as well as more severe airflow obstruction, than those who are exposed to only one type of smoke, according to the results of a new population-based study conducted by researchers in Colombia.

21 May 2013

UTMB researchers awarded grant to study gene therapy techniques to eliminate neuropathic pain

University of Texas Medical Branch at Galveston researchers have been awarded a five-year, $1.8 million grant by the National Institute of Neurological Disorders and Stroke to apply the techniques of gene therapy to the problem of neuropathic pain - that is, pain that arises from a malfunction in the nervous system.

21 May 2013

New telerehabilitation approach lets physical therapists assess LBP patients with accuracy

A new "telerehabilitation" approach lets physical therapists assess patients with low back pain over the Internet, with good accuracy compared with face-to-face examinations, reports a study in the May 15 issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

21 May 2013

Scientists design 'fishing' technique to show health benefits of foods

New research suggests that a compound abundant in the Mediterranean diet takes away cancer cells' "superpower" to escape death.

21 May 2013

Lund University researchers map significance of heredity for atherosclerotic disease

Researchers at Lund University in Sweden have mapped the significance of heredity for common forms of atherosclerotic disease. No studies have previously examined whether different forms of the disease share heredity.

21 May 2013

Genetic markers improve detection of individuals with high risk for CHD

The study comprised over 24,000 Finnish subjects and was led by Professor Samuli Ripatti. The results revealed that a panel of 28 genetic markers improved detection of individuals with high risk for coronary heart disease (10-year risk ≥20%) over traditional risk factors.

21 May 2013

New study finds link between AAS use and mental health

There is a link between use of anabolic-androgenic steroids and reduced mental health later in life. This is the main conclusion of a new study on elite male strength athletes that researchers from the University of Gothenburg recently published in the British Journal of Sports Medicine.

21 May 2013

Researchers pinpoint catalytic trigger for onset of Alzheimer's disease

Researchers have pinpointed a catalytic trigger for the onset of Alzheimer's disease - when the fundamental structure of a protein molecule changes to cause a chain reaction that leads to the death of neurons in the brain.

21 May 2013

Recombinant human albumin from Novozymes Biopharma helps innovative dry eye therapy move into clinical trials

Novozymes Biopharma, part of Novozymes A/S world leader in bioinnovation, today announced that an ophthalmic solution made using its recombinant human albumin, has been approved for Phase I/II development by the FDA.

20 May 2013

FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare diseases, today announced that the U.S. Food and Drug Administration granted Breakthrough Therapy designation to sebelipase alfa for the treatment of early onset lysosomal acid lipase deficiency, also known as Wolman disease.

20 May 2013

CEO Roundtable on Cancer accredits UW Medicine with CEO Cancer Gold Standard

UW Medicine, a leading healthcare provider serving Seattle and the Northwest, is leading by example when it comes to promoting workplace wellness and encouraging healthier behavior.

20 May 2013

Researchers examine how BRD4 contributes to sustained presence of NF-kappa B in cancer cells

In a new study described in the journal Oncogene, researchers reveal how a key player in cell growth, immunity and the inflammatory response can be transformed into a primary contributor to tumor growth.

20 May 2013

GE Healthcare initiates global public awareness campaign on cancer prevention

GE Healthcare has today launched its third annual #GetFit global public awareness campaign on cancer prevention. This year's campaign leverages social media channels including Instagram, Sina Weibo in China, and Twitter to enable participation, interaction and engagement.

20 May 2013

Study shows people with SE-AN can be treated with outpatient treatment programme

Patients with the most severe and dangerous form of chronic anorexia are more likely to make a significant improvement towards recovery and stay in therapy if traditional psychological treatments are re-focused from weight gain to quality of life issues.

20 May 2013

XenoPort's Arbaclofen placarbil fails to meet co-primary endpoints in Phase 3 clinical trial

XenoPort, Inc. announced today top-line results from its pivotal Phase 3 clinical trial of arbaclofen placarbil for the treatment of patients with spasticity due to multiple sclerosis.

20 May 2013

Novel medicine for chronic wound treatment

Every 20 seconds, a limb is lost as a consequence of diabetic foot ulcer that does not heal. To date, medical solutions that can change this situation are very limited.

20 May 2013

Cell Therapeutics announces issuance of final benefit assessment report for PIXUVRI

Cell Therapeutics, Inc. today reported that Germany's Federal Joint Committee has issued its final benefit assessment report for PIXUVRI (pixantrone), which is indicated as a monotherapy for the treatment of adult patients with aggressive B-cell non-Hodgkin lymphoma (NHL) who have failed two or three prior lines of therapy.

20 May 2013

AGA Research Foundation announces recipients of 2013 Student Research Fellowship Award

The American Gastroenterological Association Research Foundation has announced the 2013 Student Research Fellowship Award recipients. The awards are intended to stimulate interest in research careers in digestive diseases among high school, undergraduate, graduate and medical school students.

20 May 2013

Measuring genetic diversity within tumor predicts outcomes of patients with head and neck cancer

A new measure of the heterogeneity - the variety of genetic mutations - of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer.

20 May 2013

Medical Condition News

AbbVie starts Phase 3 clinical study of atrasentan in patients with diabetic nephropathy

People exposed to wood and tobacco smoke are at greater risk for developing COPD

UTMB researchers awarded grant to study gene therapy techniques to eliminate neuropathic pain

New telerehabilitation approach lets physical therapists assess LBP patients with accuracy

Scientists design 'fishing' technique to show health benefits of foods

Lund University researchers map significance of heredity for atherosclerotic disease

Genetic markers improve detection of individuals with high risk for CHD

New study finds link between AAS use and mental health

Researchers pinpoint catalytic trigger for onset of Alzheimer's disease

Recombinant human albumin from Novozymes Biopharma helps innovative dry eye therapy move into clinical trials

FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

CEO Roundtable on Cancer accredits UW Medicine with CEO Cancer Gold Standard

Researchers examine how BRD4 contributes to sustained presence of NF-kappa B in cancer cells

GE Healthcare initiates global public awareness campaign on cancer prevention

Study shows people with SE-AN can be treated with outpatient treatment programme

XenoPort's Arbaclofen placarbil fails to meet co-primary endpoints in Phase 3 clinical trial

Novel medicine for chronic wound treatment

Cell Therapeutics announces issuance of final benefit assessment report for PIXUVRI

AGA Research Foundation announces recipients of 2013 Student Research Fellowship Award

Measuring genetic diversity within tumor predicts outcomes of patients with head and neck cancer

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News